Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
American Heart Association (13GRNT17200013)
American Heart Association (20PRE35210991)
National Science Foundation (1438537)
National Science Foundation (1843479)
National Institutes of Health (EB031013)
- License Information
-
More Information
Article History
Received: 3 August 2023
Revised: 25 October 2023
Accepted: 13 November 2023
First Online: 23 November 2023
Declarations
:
: This study was approved by the Institutional Review Board of Tulane University (Protocol Nos. 944474 and 2020–268).
: The enrolled subjects and/or their parents/guardians completed a consent and/or assent forms indicating that the blood was withdrawn for research purposes only. They were informed of the risks (minimal discomfort, bruising) and could freely withdraw from participation.
: Not applicable.
: N. K., D. L., and D. B. K. have the following conflicts of interest to disclose: N. K. owns equity in and has employment at Levisonics Inc. She is also an inventor listed on the patent PCT/US21/15336 (pending). D. L. owns equity in Levisonics, and he is an inventor listed on the patent PCT/US2018/014879 (issued). D. B. K. owns equity in Levisonics, and he is also an inventor on patents PCT/US14/55559 (issued), PCT/US2018/014879 (issued), and PCT/US21/15336 (pending).
